Company Develops a New Approach to Nerve Repair

Mar 12, 2007

A new company, Neurotex Ltd, has been established to develop novel silk-based materials that have the potential to provide a new generation of nerve repair materials and treatments.

Neurotex Ltd is a joint venture company, bringing together the expertise of Professor John Priestley, Head of Neuroscience at Queen Mary’s School of Medicine and Dentistry, and the unique silk-based materials technology developed by Dr David Knight, and Dr Nick Skaer of Oxford Biomaterials Ltd. Dr Richard Skipper has been appointed Chief Executive Officer of the new company.

Neurotex Ltd is developing a range of patented devices for the repair of damaged nerves using a modified wild silk developed by Oxford Biomaterials, called Spidrex®.

Spidrex has biological and mechanical properties that make it a highly attractive candidate for nerve repair devices. Initial studies have shown Spidrex to be highly supportive of directed nerve growth with low immunotoxicity. Professor John Priestley, Scientific Founder of Neurotex expects that the research will lead to treatment for peripheral nerve injury, and may eventually lead to treatments for repairing damaged spinal cords – however, he cautions that spinal cord damage is far more complex and a much longer term goal.

Professor John Prestley, Scientific Founder of Neurotex said; “For us it’s an ambitious but realistic goal to repair the peripheral nervous system. If you damage a peripheral nerve, so long as it has a support to follow, the nerve should regrow and hopefully the nerve injury will repair itself. If you damage the spinal cord, however, there are lots of things that will try and prevent the regrowth taking place, such as natural inhibitory components. To repair a damaged spinal cord, we will need different types of tubes and will have to combine other approaches such as stem cells, growth factors or other additives. So it’s a much longer term goal, but the rewards are potentially much greater.” The Kinetique Biomedical Seed Fund has invested £250,000 to develop devices for use in peripheral nerve injury repair.

Source: Queen Mary, University of London

Explore further: Nerve cells and blood vessels in eye 'talk' to prevent disease, study finds

Related Stories

Yahoo unveils new online video series

13 minutes ago

US Internet giant Yahoo said it was expanding its online offerings, unveiling 18 new video series with which it hopes to attract a larger audience and advertisers.

Groups want review of Shell's Arctic regulatory filings

33 minutes ago

Two groups petitioned the U.S. Securities and Exchange Commission on Monday for an investigation of Royal Dutch Shell PLC and what the groups call misstatements in regulatory filings regarding the risk of a catastrophic oil ...

Apple's Mac is selling strong, iPad not so much

56 minutes ago

Apple's iPhone was again the company's star in the first three months of the year. The tech giant sold 61 million iPhones, or 40 percent more than in the same period a year ago. That represented about two-thirds ...

Claims about the decline of the West are 'exaggerated'

8 hours ago

A new paper by Oxford researchers argues that some countries in Western Europe, and the USA, Canada, Australia and New Zealand now have birth rates that are now relatively close to replacement, that the underlying trend in ...

Recommended for you

Inaccurate reporting jeopardizing clinical trials

Apr 26, 2015

The team led by Dr Sheena Cruickshank of the Faculty of Life Sciences and Professor Andy Brass from the School of Computer Science analysed 58 papers on research into inflammatory bowel disease published between 2000 and ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.